Target intelligence / Profile preview

Eleutherococcus senticosus

Molecular classification
Botanical source, Natural product
01

Overview

Eleutherococcus senticosus, widely known as Siberian ginseng or eleuthero, is a woody shrub native to Northeast Asia and is recognized primarily as a botanical source of bioactive compounds rather than a single molecular target (Source: NCCIH). It contains a variety of active constituents, most notably eleutherosides B and E, which are credited with its adaptogenic properties (Source: PubMed, PMID: 21718777). These compounds are thought to enhance the body's non-specific resistance to stressors by modulating the hypothalamic-pituitary-adrenal (HPA) axis and influencing metabolic processes (Source: Journal of Ethnopharmacology). In clinical contexts, it is often utilized to combat fatigue, improve physical performance, and support immune function (Source: Mayo Clinic). However, because it is a complex mixture of phytochemicals, it does not fit the definition of a discrete therapeutic receptor or enzyme target. Analysts should note its potential for significant drug-drug interactions, particularly with anticoagulants and antidiabetic medications (Source: Drugs.com).

Other names
Siberian ginsengEleutheroCiwujiaAcanthopanax senticosusDevil's bushMany-prickle acanthopanax
02

Mechanism of action

Acts as an adaptogen by modulating the hypothalamic-pituitary-adrenal (HPA) axis and increasing the expression of molecular chaperones such as Hsp70 (Source: PubMed, PMID: 18536979). It also stimulates the production of T-lymphocytes and natural killer cells to enhance immune surveillance and exhibits antioxidant properties through the scavenging of reactive oxygen species (Source: Memorial Sloan Kettering Cancer Center).

03

Biological functions

Adaptogenic activityImmune system modulationAnti-fatigueStress response regulationNeuroprotection
04

Disease associations

FatigueStressImmune deficiencyCognitive impairmentIschemic stroke (experimental models)
05

Safety considerations

HypertensionInsomniaPalpitationsDrug-drug interactions via CYP450 inhibition (Source: PubMed, PMID: 22533428)Hypoglycemia risk in diabetic patientsPotential interference with digoxin assays
06

Interacting drugs

Warfarin

6 more in the full profile.

07

Biomarkers

CortisolInterleukin-2Interferon-gammaBlood glucoseHeat shock protein 70 (Hsp70)

Beyond the preview

Go deeper on Eleutherococcus senticosus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eleutherococcus senticosus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call